ScholarX

Browsing by El-Khoueiry, AB[El-Khoueiry, Anthony B.]Author

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 6 of 6

SCIESCOPUS
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trialopen access

Yau, T[Yau, Thomas]; Kang, YK[Kang, Yoon-Koo]; Kim, TY[Kim, Tae-You]; El-Khoueiry, AB[El-Khoueiry, Anthony B.]; Santoro, A[Santoro, Armando]; Sangro, B[Sangro, Bruno]; Melero, I[Melero, Ignacio]; Kudo, M[Kudo, Masatoshi]; Hou, MM[Hou, Ming-Mo]; Matilla, A[Matilla, Ana], et al.

ArticleIssue Date2020CitationJAMA ONCOLOGY, v.6, no.11PublisherAMER MEDICAL ASSOC
SCIESCOPUS
Investigating the novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager, AFM24, to leverage the innate immune system: Interim results from the colorectal cancer (CRC) cohort

Cervantes, A[Cervantes, Andres]; Rivas, D[Rivas, Delcia]; Lee, SH[Lee, Se-Hoon]; Thomas, JS[Thomas, Jacob Stephen]; Kim, YJ[Kim, Yu Jung]; Saavedra, O[Saavedra, Omar]; Shim, BY[Shim, Byoung Yong]; Kohlhas, L[Kohlhas, Laura]; Hintzen, G[Hintzen, Gabriele]; Emig, M[Emig, Michael], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Leveraging innate immunity with AFM24, a novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager: Interim results for the non-small cell lung cancer (NSCLC) cohort

El-Khoueiry, AB[El-Khoueiry, Anthony B.]; Rivas, D[Rivas, Delcia]; Lee, SH[Lee, Se-Hoon]; Thomas, JS[Thomas, Jacob Stephen]; Kim, YJ[Kim, Yu Jung]; Cervantes, A[Cervantes, Andres]; Saavedra, O[Saavedra, Omar]; Shim, BY[Shim, Byoung Yong]; Kohlhas, L[Kohlhas, Laura]; Hintzen, G[Hintzen, Gabriele], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (aHCC): Long-term results from CheckMate 040.

El-Khoueiry, AB[El-Khoueiry, Anthony B.]; Yau, T[Yau, Thomas]; Kang, YK[Kang, Yoon-Koo]; Kim, TY[Kim, Tae-You]; Santoro, A[Santoro, Armando]; Sangro, B[Sangro, Bruno]; Melero, I[Melero, Ignacio]; Kudo, M[Kudo, Masatoshi]; Hou, MM[Hou Ming-Mo]; Matilla, A[Matilla, Ana], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.3PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial

Kelley, RK[Kelley, Robin Kate]; Ryoo, BY[Ryoo, Baek-Yeol]; Merle, P[Merle, Philippe]; Park, JW[Park, Joong-Won]; Bolondi, L[Bolondi, Luigi]; Chan, SL[Chan, Stephen L.]; Lim, HY[Lim, Ho Yeong]; Baron, AD[Baron, Ari D.]; Parnis, F[Parnis, Francis]; Knox, J[Knox, Jennifer], et al.

ArticleIssue Date2020CitationESMO OPEN, v.5, no.4, pp.1 - 9PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
Zanidatamab (ZW25) in HER2-expressing gastroesophageal adenocarcinoma (GEA): Results from a phase I study.

Meric-Bernstam, F[Meric-Bernstam, Funda]; Hamilton, EP[Hamilton, Erika P.]; Beeram, M[Beeram, Muralidhar]; Hanna, DL[Hanna, Diana L.]; El-Khoueiry, AB[El-Khoueiry, Anthony B.]; Kang, YK[Kang, Yoon-Koo]; Lee, KW[Lee, Keun Wook]; Lee, J[Lee, Jeeyun]; Rha, SY[Rha, Sun Young]; Chaves, JM[Chaves, Jorge M.], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.3PublisherLIPPINCOTT WILLIAMS & WILKINS
1
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어